Highest Score

Ranked by analysis score
Ranks this page's recent reports by score.
Trimble Inc.
TRMB·Technology
A ★★★★Buy
Current$58.44
Target$83.95
Return+43.7%
Aug 15, 2026

Trimble is rapidly compounding value as an elite, high-margin construction software ecosystem trading at an unwarranted legacy-hardware discount, though investors must navigate the near-term friction of logistics impairments and internal accounting remediations.

Score
89
Ferguson Enterprises Inc.
FERG·Industrials
A ★★★★Buy
Current$263.78
Target$297.60
Return+12.8%
Aug 13, 2026

Ferguson is a fiercely dominant, highly localized industrial distributor capitalizing on the US infrastructure and data center supercycle, offering investors a uniquely discounted entry point relative to distribution peers despite facing lingering headwinds in the macro housing market.

Score
89
Embraer S.A.
EMBJ·Industrials
A ★★★★Buy
Current$73.96
Target$93.50
Return+26.4%
Aug 13, 2026

Backed by a record $34.5 billion backlog and soaring free cash flow, Embraer is a fiercely executing aerospace powerhouse trading at a deep discount to peers, though investors must vigilantly monitor lingering U.S. tariff pressures and Pratt & Whitney supply chain bottlenecks.

Score
89
Progyny, Inc.
PGNY·Healthcare
A ★★★★Buy
Current$28.10
Target$38.70
Return+37.7%
Aug 10, 2026

Progyny is the undisputed, highly profitable tollbooth of the U.S. fertility industry, trading at a massively depressed valuation due to a one-off client loss, though investors must vigilantly monitor the long-term biological threat of GLP-1 weight-loss drugs suppressing national IVF demand.

Score
89
AXIA Energia SA
AXIA·Utilities
A ★★★★Buy
Current$10.50
Target$14.44
Return+37.5%
Aug 10, 2026

AXIA Energia is an unassailable infrastructural monopoly generating explosive free cash flow as it pivots to unregulated free-market pricing, offering deep undervaluation and a massive dividend, though investors must tolerate inherent Brazilian hydrological and interest rate volatility.

Score
89
Jazz Pharmaceuticals plc
JAZZ·Healthcare
A ★★★★Buy
Current$256.65
Target$310.00
Return+20.8%
Aug 7, 2026

Jazz is successfully utilizing the immense cash flows from its resilient neuroscience monopoly to aggressively fund an explosive, deeply undervalued oncology pipeline, though investors must remain highly vigilant regarding competitive encroachment from once-nightly narcolepsy alternatives.

Score
89
AMETEK, Inc.
AME·Industrials
A ★★★★Buy
Current$254.05
Target$289.40
Return+13.9%
Aug 7, 2026

AMETEK is a phenomenally profitable, cash-gushing industrial compounder that mitigates organic cyclicality through a ruthless, highly accretive M&A playbook, though its elevated valuation demands flawless, uninterrupted execution from management.

Score
89
Ameren Corporation
AEE·Utilities
A ★★★★Buy
Current$109.97
Target$124.00
Return+12.8%
Aug 1, 2026

Ameren offers a highly secure 6-8% earnings growth trajectory supercharged by $25 billion in legally protected hyperscaler data center investments, though investors must navigate the persistent friction of state rate cases and continuous capital raising.

Score
89
Willis Towers Watson Public Limited Company
WTW·Financials
S ★★★★★Strong Buy
Current$325.71
Target$366.56
Return+12.5%
Nov 2, 2026

Willis Towers Watson combines a durable advisory and insurance brokerage franchise with attractive cash generation and margin expansion opportunities, although transformation costs and competitive talent pressure remain key risks.

Score
88
Cirrus Logic, Inc.
CRUS·Technology
S ★★★★★Strong Buy
Current$109.82
Target$134.72
Return+22.7%
Nov 1, 2026

Cirrus Logic offers high-return semiconductor design expertise, strong cash flow, and an attractive valuation, although its extraordinary dependence on Apple exposes earnings to concentrated customer and product-cycle risks.

Score
88
The New York Times Company
NYT·Communication Services
S ★★★★★Strong Buy
Current$69.58
Target$78.00
Return+12.1%
Oct 26, 2026

New York Times combines premium subscription economics, strong cash conversion, and a durable media franchise at attractive historical cash-flow multiples, although AI-driven discovery disruption and slower subscriber growth threaten future expansion.

Score
88
Carnival Corporation Ltd.
CCL·Consumer Discretionary
A ★★★★Buy
Current$24.54
Target$36.78
Return+49.9%
Oct 1, 2026

Carnival's record bookings, rising cash flow and rapid deleveraging are available at a steep peer discount, though high debt, fuel costs and discretionary-demand sensitivity keep the thesis cyclical.

Score
88